We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

PTX Prescient Therapeutics Limited

-0.001 (-2.33%)
Last Updated: 10:15:27
Delayed by 20 minutes

Prescient Therapeutics Financial Summary

The current PTX market cap is 33.82M. The company's latest EPS is AUD -0.0087 and P/E is -4.60.

Year End 30 June 2023 20192020202120222023
Total Revenue 1.65M1.08M1.24M1.89M2.43M
Operating Income -3.9M-3.42M-4.19M-5.21M-7.46M
Net Income -3.8M-3.32M-4.15M-5.12M-7.01M
Year End 30 June 2023 20192020202120222023
Total Assets 15.01M12.07M20.97M17.62M28.11M
Total Liabilities 686k884k540k856k2.03M
Total Equity 14.32M11.19M20.43M16.76M26.08M

Cash Flow

Year End 30 June 2023 20192020202120222023
Operating -4.2M-2.32M-3.97M-4.31M-6.19M
Investing N/A N/A -2k-4k N/A
Financing 8.37M N/A 12.75M428k-172k
Market Cap 33.82M
Price to Earnings Ratio -4.60
Price to Sales Ratio 13.33
Price to Cash Ratio 5.48
Price to Book Ratio 1.24
Dividend Yield -

Share Statistics

Shares Outstanding 805.32M
Average Volume (1 week) 1.45M
Average Volume (1 Month) 762.24k
52 Week Change -51.72%
52 Week High 0.105
52 Week Low 0.04
Spread (Intraday) 0 (2.38%)

Company Info

Company Name Prescient Therapeutics Limited
Address level 4
melbourne, victoria 3205
Industry biological pds,ex diagnstics (2836)

Your Recent History

Delayed Upgrade Clock